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Bcmfs1, a novel major facilitator superfamily gene from Botrytis cinerea, was cloned, and replacement and
overexpression mutants were constructed to study its function. Replacement mutants showed increased sen-
sitivity to the natural toxic compounds camptothecin and cercosporin, produced by the plant Camptotheca
acuminata and the plant pathogenic fungus Cercospora kikuchii, respectively. Overexpression mutants displayed
decreased sensitivity to these compounds and to structurally unrelated fungicides, such as sterol demethylation
inhibitors (DMIs). A double-replacement mutant of Bcmfs1 and the ATP-binding cassette (ABC) transporter
gene BcatrD was more sensitive to DMI fungicides than a single-replacement mutant of BcatrD, known to
encode an important ABC transporter of DMIs. The sensitivity of the wild-type strain and mutants to DMI
fungicides correlated with Bcmfs1 expression levels and with the initial accumulation of oxpoconazole by
germlings of these isolates. The results indicate that Bcmfs1 is a major facilitator superfamily multidrug
transporter involved in protection against natural toxins and fungicides and has a substrate specificity that
overlaps with the ABC transporter BcatrD. Bcmfs1 may be involved in protection of B. cinerea against plant
defense compounds during the pathogenic phase of growth on host plants and against fungitoxic antimicrobial
metabolites during its saprophytic phase of growth.
Microorganisms in their natural environment need to pro-
tect themselves from adverse effects caused by natural toxic
compounds. This also accounts for Botrytis cinerea Pres. ex Fr.
[anamorph of Botryotinia fuckeliana (De Bary)], a plant-patho-
genic fungus with a wide host range that can also grow as
a saprophyte (8). Thus, the fungus has to cope with natural
toxic compounds produced by host plants during pathogenesis
and with antagonistic microorganisms during the saprophytic
phase. ATP-binding cassette (ABC) and major facilitator su-
perfamily (MFS) transporters can enable the fungus to survive
exposure to toxic compounds. These membrane-bound pro-
teins are known to provide protection against a wide range of
natural toxic compounds and xenobiotics (12). ABC transport-
ers use the energy of ATP hydrolysis to transport compounds
over membranes. They may have a broad substrate range in-
cluding unrelated chemicals such as sugars, inorganic ions,
heavy metals, peptides, amino acids, oligopeptides, polysaccha-
rides, proteins, and drugs (18). Transporters located in plasma
membranes can transport toxic compounds from the inner
leaflet of these membranes to the outer environment of cells,
thereby reducing accumulation of the compounds in cells (14).
ABC transporter activity in filamentous fungi involved in en-
ergy-dependent efflux of fungicides has been demonstrated for
Aspergillus nidulans (3) and B. cinerea (33). Overexpression of
ABC transporters can result in resistance to sterol demethyl-
ation inhibitors (DMIs) as reported for A. nidulans (3, 11),
B. cinerea (17), Candida albicans (24), Penicillium digitatum
(20), and Saccharomyces cerevisiae (18). MFS transporters may
also prevent accumulation of toxic compounds in cells, but
their activity is driven by the proton-motive force over mem-
branes (21). MFS transporters from C. albicans (5) and S.
cerevisiae (1) are involved in protection against exogenous toxic
compounds, such as DMIs. In filamentous fungi, a number of
MFS transporters are known to mediate the secretion of en-
dogenously produced toxins (22), such as aflatoxin, cerco-
sporin, Helminthosporium carbonum toxin (HC toxin), and
trichothecenes by Aspergillus flavus (P. K. Chang, J. Yu, D.
Bhatnagar, and T. E. Cleveland, Abstr. 99th Gen. Meet. Am.
Soc. Microbiol., abstr. O-31, p. 501, 1999), Cercospora kikuchii
(6), Cochliobolus carbonum (23), and Fusarium sporotrichioides
(2), respectively. This may result in self-protection of the pro-
ducing organisms against these compounds. So far, a role of
MFS transporters of filamentous fungi in protection against
synthetic drugs, such as fungicides, has not been reported.
Recently we demonstrated that B. cinerea possesses multiple
ABC and MFS transporter genes (16, 33) and showed that the
ABC transporter BcatrB plays a role in protection against the
plant defense compound resveratrol and phenylpyrrole fungi-
cides (29). Similarly, the ABC transporter BcatrD provides
protection against DMIs (17). Overexpression of these trans-
porters in laboratory-generated mutants resulted in multidrug
resistance to fungicides and unrelated chemicals (16). This
mechanism may also apply to fungicide resistance develop-
ment under field conditions (7, 19).
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In this paper, we describe the isolation of the MFS gene
Bcmfs1 from B. cinerea. We constructed Bcmfs1 replacement
and overexpression mutants and phenotyped these mutants for
sensitivity to compounds from different chemical classes. The
differential sensitivity of the mutants to the DMI fungicide
oxpoconazole correlated with expression levels of Bcmfs1 and
with accumulation of the fungicide by germlings of the mu-
tants. We propose that Bcmfs1 functions in protection against
natural toxins, DMI fungicides, and other unrelated com-
pounds. Hence, Bcmfs1 is the first MFS multidrug transporter
of a filamentous fungus for which multiple substrates have
been described.
MATERIALS AND METHODS
Fungal strains. B. cinerea strain B05.10 (4), provided by P. Tudzynski (Institut
fu¨r Botanik, Westfa¨lische Wilhelms-Universita¨t, Mu¨nster, Germany), is a hap-
loid strain derived from SAS56 isolated by F. Faretra (Universita` of Bari, Bari,
Italy). B05.10 was used as the parental isolate in all experiments. B05.10 and
mutants constructed (Table 1) were maintained on malt extract agar plates
Oxoid Ltd., Basingstoke, Hampshire, England) amended with 0.2% yeast extract
(Oxoid) at 20°C. Formation of conidia was induced by irradiation with near-UV
light for 24 h after 3 days of incubation and prolonged incubation for 3 to 7 days.
Conidial suspensions were stored in 15% glycerol at 20°C.
Plasmids carrying a hygromycin resistance cassette (pLOB1) and a nourseo-
thricin resistance cassette (pNR2) were gifts from Jan van Kan, Sander Schouten,
and Ilona Kars (Laboratory of Phytopathology, Wageningen University,
Wageningen, The Netherlands). pNR2 is derived from pNR1 (kindly provided by
Paul and Bettina Tudzynski, Westfa¨lische Wilhelms-Universita¨t, Mu¨nster, Ger-
many). pLOB1 carries the Escherichia coli hygromycin phosphotransferase-
encoding gene hph, and pNR2 carries the Streptomyces noursei nourseothricin
acetyltransferase-encoding gene nat-1 (Werner-Bioagents, Jena, Germany) un-
der control of the A. nidulans oliC promoter and a B. cinerea -tubulin tran-
scription terminator fragment.
Compounds. Oxpoconazole, iprodione, and prochloraz (technical grade) were
obtained from Ube Industries, Ltd. (Ube, Yamaguchi, Japan), captan and tebu-
conazole were obtained from Bayer AG (Leverkusen, Germany), cyprodinil and
pyrifenox were obtained from Syngenta (Stein, Switzerland), fenarimol was ob-
tained from Eli Lilly and Company (Indianapolis, Ind.), and fluazinam was
obtained from ISK Bioscience Co. (Mentor, Ohio). Barbaloin, camptothecin,
cercosporin, colchicine, cycloheximide, 8-methoxypsoralen, reserpine, rhoda-
mine 6G, rose bengal, toluidine blue, and vincamine were purchased from Sigma
(St. Louis, Mo.), globulol and patchoulol were purchased from Fluka Chemie
AG (Buchs, Switzerland), and hypericin and pseudohypericin were purchased
from Planta Naturstoffe (Vienna, Austria).
Cloning of Bcmfs1. Cloning of Bcmfs1 was performed following an approach
similar to that described for BcatrD (17). An Expressed Sequence Tags (EST)
fragment of Bcmfs1 (Fig. 1A) obtained by PCR amplification was used for
screening of a genomic library of strain SAS56 in EMBL3, provided by A. ten
Have (Laboratory of Phytopathology, Wageningen University). Positive and pu-
rified phages were subcloned in pBluescript II SK and sequenced. DNA manip-
ulations were performed according to standard methods (25). Escherichia coli
strain DH5 was used for propagation of the constructs.
cDNA was amplified by reverse transcription-PCR using the SUPERSCRIPT
One-Step reverse transcription-PCR with PLATINUM Taq system (Life Tech-
nologies Inc., Breda, The Netherlands). Homology of the putative protein se-
quence derived from Bcmfs1 cDNA with other MFS proteins was calculated
using the Clustal method by the program Megalign (DNAstar, Madison, Wis.).
Construction of Bcmfs1 replacement mutants. In an 8.5-kb XbaI-SalI subclone
containing the full-length Bcmfs1 gene and its flanking regions, the 2.4-kb
EcoRV fragment containing Bcmfs1 was replaced by the hygromycin-resistance
cassette (OHT cassette) from pLOB1 to construct the replacement vector p1-H
(Fig. 1B). Before transformation, the plasmid was linearized with XhoI. Trans-
formation was performed as described for replacement of the BcatrD gene (17).
Construction of double-replacement mutants. In an 8.5-kb XbaI-SalI subclone,
the 1.1-kb SacI-ClaI fragment was replaced by the nourseothricin resistance
cassette (ONT cassette) from pNR to construct the replacement vector p1-N
(Fig. 1C). For the construction of double-replacement mutants, protoplasts from
BcatrB4 (29) or BcatrD-8 (17) were transformed with 1 g of p1-N. Before
transformation, the plasmid was linearized with XhoI. The selection and purifi-
cation of putative transformants were performed by three successive transfers on
malt extract agar amended with 100 mg of nourseothricin (Werner-Bioagents)
liter1 followed by single-spore isolation.
Construction of Bcmfs1 overexpression mutants. A subclone containing the
5.5-kb XbaI-SalI fragment (Fig. 1A) in pBluescript II SK was used to generate
overexpression mutants by cotransformation with pLOB1 to protoplasts of
B05.10 as described previously (17).
Southern and Northern blot analysis. Southern and Northern blot analyses
were performed as described previously (17). In Southern blot experiments, 5 g
of genomic DNA was digested with EcoRV and hybridized with the 5.5-kb
XbaI-SalI probe to characterize Bcmfs1 single-replacement mutants or the 3.6-kb
XbaI-ApaI probe to characterize double-replacement mutants as presented in
Fig. 1A. In Northern expression analysis experiments, 10 g of total RNA was
loaded on agarose gel (1.6%), and the blots were hybridized with the EST
fragment of Bcmfs1 (Fig. 1A).
Phenotype assay. The phenotype of replacement and overexpression mutants
was studied by investigating their sensitivity to compounds in radial growth
experiments as described previously (7). Drops of spore suspension (3 l) of B.
cinerea (106 conidia ml1) were inoculated on plates with synthetic medium
amended with chemicals from 100 concentrated stock solutions in methanol.
The plates were incubated at 20°C in the dark for 3 days. The sensitivity to
camptothecin, cercosporin, and other photosensitizers was investigated in the
light as well as in the dark. Effective concentrations inhibiting radial growth by
50% (EC50s) of chemicals were calculated from dose-response curves using
Excel 97. Experiments were repeated three times, and statistical analysis of the
EC50s was performed by the least-significant-difference test (t test).
Accumulation of oxpoconazole. Accumulation experiments were performed as
described previously (13). Germling suspensions (4 mg wet weight per ml) in 0.05
M potassium phosphate buffer (pH 6.0) containing D-glucose (10 g liter1) were
preincubated on a reciprocal shaker at 20°C and 180 rpm for 20 min. [14C]ox-
poconazole (initial external concentration, 30 M; 750 Bq nmol1) was added
from a 100 concentrated stock solution in methanol. Samples (5 ml) taken from
TABLE 1. B. cinerea strains used in this study
Strain Character Reference
B05.10 Wild-type strain 4
BcatrB4 BcatrB replacement mutant derived from B05.10 carrying the hygromycin resistance cassette 29
BcatrD-8 BcatrD replacement mutant derived from B05.10 carrying the hygromycin resistance cassette 17
Bcmfs1–16 and Bcmfs1–18 Bcmfs1 replacement mutants derived from B05.10 carrying the hygromycin resistance cassette This study
OV1–23, OV1–48, and OV1–13 Bcmfs1 overexpression mutants derived from B05.10 carrying the hygromycin resistance cassette
with a low, medium, and high level of resistance to oxpoconazole, respectively
This study
HR-9 Reference strain derived from B05.10 carrying an ectopic integration of the hygromycin resistance
cassette
17
B1-22 BcatrB and Bcmfs1 double-replacement mutant derived from BcatrB4 carrying both the hygromycin
and nourseothricin resistance cassettes
This study
D1-45 BcatrD and Bcmfs1 double replacement mutant derived from BcatrD-8 carrying both the hygromycin
and nourseothricin resistance cassettes
This study
HNR-4 Reference strain derived from B05.10 carrying an ectopic integration of both the hygromycin and
nourseothricin resistance cassettes
This study
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the suspensions at various time intervals were collected and washed three times
with the same buffer on a GF6 microfiber glass filter (Schleicher & Schuell,
Dassel, Germany). Radioactivity in mycelium was extracted with scintillation
liquid (LUMASAFE PLUS, LUMACLSC B.V., Groningen, The Netherlands)
for 1 day and counted in a liquid scintillation spectrometer BECKMAN
LS6000TA (Beckman Coulter Inc., Fullerton, Calif.).
Virulence assay. Detached leaves of tomato (cv. Moneymaker Cf4) were
placed in florist foam on wet paper in plastic chambers. Drops of spore suspen-
sions (1 l) of B. cinerea (2  106 conidia ml1) in B5 medium [1% sucrose, 10
mM (NH4)H2PO4, 0.31% Gamborg B5 medium elements (Duchefa, Haarlem,
The Netherlands)] were spotted onto the surface of the tomato leaves. The
wild-type isolate B05.10 and the mutants were inoculated on two halves of the
same leaf. Inoculated leaves were incubated in closed boxes at 20°C in the dark.
Diameters of lesions were measured 3 days after inoculation. Experiments were
performed twice.
Nucleotide sequence accession number. The full-length Bcmfs1 gene of B. ci-
nerea has been submitted to GenBank under accession number AF238225.
RESULTS
Cloning of Bcmfs1. Screening of a phage library of B. cinerea
with an EST fragment of Bcmfs1 (Fig. 1A) resulted in the
selection of a phage containing the full-length Bcmfs1 gene.
Comparison of the sequence of genomic DNA and cDNA
revealed that Bcmfs1 contains a 1,794-bp open reading frame
(ORF) interrupted by five introns. The introns vary in size
from 53 to 92 bp and are distributed over the whole ORF of
Bcmfs1 (Fig. 1A). The 5	 and 3	 sequences of these introns
match known intron sequences from filamentous fungi (31).
The putative ORF of Bcmfs1 has two ATG codons at the 5	
end. Hence, the first codon may not belong to the ORF of
Bcmfs1.
The BLAST database (http://www.ncbi.nlm.nih.gov/BLAST/)
provided by the National Center for Biotechnology Informa-
tion demonstrated that Bcmfs1 is homologous to other MFS
transporters, such as aflT from Aspergillus parasiticus (54.1%
identity), CFP1 from C. kikuchii (36.6% identity), TOXA from
C. carbonum (35.4% identity), and ORF10 from Aspergillus
terreus (35.6% identity). Hydropathy analysis (http://www.ch
.embnet.org/software/TMPRED_form.html) provided by the
Swiss Institute of Bioinformatics predicts that Bcmfs1 has 14
transmembrane domains (data not shown).
Bcmfs1 single-replacement mutants. Protoplasts of B. cine-
rea strain B05.10 were transformed with linearized p1-H (Fig.
1B). Thirty putative transformants were selected and purified
by single-spore isolation. Southern blot analysis of genomic
DNA from these transformants revealed that several strains
were homokaryotic transformants with a site-specific integra-
tion, including Bcmfs1-16 and Bcmfs1-18 (Fig. 2A). The
reference strain HR-9 carrying the OHT cassette and BcatrD
replacement mutant BcatrD-8 (17) showed the same bands as
the parental strain, B05.10 (Fig. 2A). The expression of the
Bcmfs1 replacement mutants Bcmfs1-16 and Bcmfs1-18 was
investigated by Northern analysis with the EST fragment of
Bcmfs1 (Fig. 1A) as a probe. The basal level of expression of
Bcmfs1 in the parental strain B05.10, the reference strain
HR-9, and BcatrD-8 was low but strongly induced after treat-
ment of germlings with oxpoconazole (30 mg liter1) for 60
min. In Bcmfs1-16 and Bcmfs1-18, neither basal nor oxpo-
conazole-induced expression was observed (Fig. 3A).
Radial growth tests demonstrated that Bcmfs1-16 and
Bcmfs1-18 had an increased sensitivity to the alkaloid camp-
tothecin (a fungitoxic compound from Camptotheca acumi-
nata) and the perylenequinone cercosporin (a host-specific
FIG. 1. Physical map of Bcmfs1 in genomic DNA from B. cinerea wild-type strain B05.10 (A) and replacement mutant of Bcmfs1 with the
hygromycin-resistance (OHT) cassette (B) or the nourseothricin-resistance (ONT) cassette (C). Southern blots of DNA from single-replacement
mutants and double-replacement mutants of Bcmfs1 were hybridized with the 5.5-kb XbaI-SalI fragment and the 3.6-kb XbaI-ApaI fragment,
respectively. Northern blots were hybridized with the EST fragment of Bcmfs1.
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toxin produced by C. kikuchii), while the reference strain HR-9
displayed almost the same sensitivity to these compounds as
the parental strain, B05.10 (Fig. 4A; Table 2). As expected, the
fungitoxic activity of the photosensitizer cercosporin was
higher in the light than in the dark (Fig. 5). The fungitoxic
activity of other photosensitizers, such as cercosporin ana-
logues (hypericin and pseudohypericin), rose bengal, toluidine
blue, 8-methoxypsoralen, and alkaloids (barbaloin, colchicine,
reserpine, and vincamine), was similar for all strains tested and
was not influenced by light (data not shown). The activity of
fungicides (captan, cyprodinil, fluazinam, iprodione, oxpocon-
azole, prochloraz, and tebuconazole) and other fungitoxic
compounds (cycloheximide and rhodamine 6G) was similar for
the wild-type strain and all Bcmfs1 single-replacement mutants
tested (results shown only for Bcmfs1-16 in Table 2). Similar
results were obtained with the botrydial analogues patchoulol
or globulol (32) (data not shown).
Double gene replacement mutants. Protoplasts of the BcatrB
replacement mutant BcatrB4 (29) and the BcatrD replace-
ment mutant BcatrD-8 (17) were transformed with linearized
p1-N (Fig. 1C). Southern analysis of genomic DNA from the
putative transformants digested with EcoRV revealed that
B1-22 and D1-45 were homokaryotic transformants (Fig.
2B). Northern analysis of the transformants demonstrated that
basal and oxpoconazole-induced expression of Bcmfs1 was not
detectable in mutants B1-22 and D1-45 (Fig. 3B).
The sensitivity of the double-replacement mutant D1-45
to the DMI fungicide oxpoconazole was higher than that of the
single-replacement mutant BcatrD-8 (Fig. 4B; Table 3). This
FIG. 2. Southern blot analysis of DNA from B. cinerea. Genomic
DNA (5 g) was digested with EcoRV and hybridized with a 5.5-kb
XbaI-SalI probe (A) and with a 3.6-kb XbaI-ApaI probe (B). Results
obtained with parental strain B05.10, Bcmfs1 replacement mutants
Bcmfs1-16 and Bcmfs1-18, reference mutant HR-9, BcatrD replace-
ment mutant BcatrD-8, BcatrB and Bcmfs1 double-replacement mu-
tant B1-22, BcatrD and Bcmfs1 double-replacement mutant D1-
45, reference mutant HNR-4, and BcatrB replacement mutant
BcatrB4 are shown.
FIG. 3. Northern blot analysis of total RNA (10 g) from germlings of B. cinerea. (A) Parental strain B05.10, Bcmfs1 replacement mutants
Bcmfs1-16 and Bcmfs1-18, reference mutant HR-9, and BcatrD replacement mutant BcatrD-8. Basal levels of expression (lanes 1) and
expression levels after treatment with 30 mg of oxpoconazole liter1 (lanes 2) are shown. (B) Parental strain B05.10, BcatrB and Bcmfs1
double-replacement mutant B1-22, BcatrD and Bcmfs1 double-replacement mutant D1-45, reference mutant HNR-4, BcatrB replacement
mutant BcatrB4, BcatrD replacement mutant BcatrD-8, and Bcmfs1 replacement mutant Bcmfs1-16. Basal levels of expression (lanes 1) and
expression levels after treatment with 30 mg of oxpoconazole liter1 (lanes 2) are shown. (C) Parental strain B05.10 (lanes 1) and the Bcmfs1
overexpression mutants OV1-23 (lanes 2), OV1-48 (lanes 3), and OV1-13 (lanes 4). Basal and induced expression levels after treatment with 3,
10, and 30 mg of oxpoconazole liter1 are shown. RNA was hybridized with the EST probe specific for Bcmfs1 (Fig. 1A). Equal loading of lanes
with RNA was checked by subsequently probing the same blot with 28S rRNA.
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FIG. 4. Activity of compounds in radial growth experiments. (A) Parental strain B05.10, reference mutant HR-9, and Bcmfs1 replacement
mutants Bcmfs1-16 and Bcmfs1-18. (B) Reference mutant HNR-4, single gene replacement mutants (BcatrB4, BcatrD-8, and Bcmfs1-16),
and double gene replacement mutants (B1-22 and D1-45). (C) Wild-type strain B05.10 and Bcmfs1 overexpression mutants (OV1-23,
OV1-48, and OV1-13).
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was not observed for the double-replacement mutant B1-22
(Fig. 4B). Differential activities against D1-45 and Bca-
trD-8 were also observed with other DMI fungicides, such as
fenarimol, prochloraz, pyrifenox, and tebuconazole (Table 3).
In contrast, camptothecin did have activity similar to that of
Bcmfs1-16, B1-22, and D1-45 (Fig. 4B).
Bcmfs1 overexpression mutants. Protoplasts of B. cinerea
strain B05.10 were transformed with the plasmid carrying the
full-length Bcmfs1 gene (Fig. 1A). The expression of Bcmfs1 in
putative transformants was investigated by Northern blot anal-
ysis. Transformants with three different levels of expression
were selected and arbitrarily classified as low (OV1-23), me-
dium (OV1-48), and high (OV1-13) (Fig. 3C). Induced expres-
sion levels of Bcmfs1 in these transformants after treatment
with oxpoconazole (3, 10, and 30 mg liter1) for 60 min cor-
related with the basal levels of expressions (Fig. 3C).
Overexpression mutants possessed a decreased sensitivity to
camptothecin, cercosporin, DMI fungicides, cyprodinil, ipro-
dione, captan, and fluazinam compared to wild-type strain
B05.10. Surprisingly, the same mutant showed an increased
sensitivity to the antibiotic cycloheximide (Fig. 4C; Table 2).
Accumulation of oxpoconazole. The accumulation of oxpo-
conazole by germlings of B. cinerea wild-type strain B05.10 was
transient in time. The mutants tested also showed this phe-
nomenon, though to a varying extent. The initial accumulation
(up to 40 min of incubation) of oxpoconazole by all strains
tested correlated with sensitivity to oxpoconazole in radial
growth experiments (Fig. 6; Tables 2 and 3). The correlation
coefficient (r2) between accumulation of oxpoconazole after 20
min of incubation and the EC50 of oxpoconazole for the dif-
ferent strains was calculated to be 0.813. Strikingly, the steady-
state level of accumulation of oxpoconazole (after 60 min of
incubation) by BcatrD-8 and D1-45 always remained
higher than that by all other strains tested (Fig. 6). Further-
more, the level of accumulation by D1-45 was significantly
higher than that by BcatrD-8.
Virulence assay. Virulence of all mutants tested (Bcmfs1-
16, Bcmfs1-18, B1-22, D1-45, OV1-23, OV1-48, OV1-
13, HR-9, and HNR-4) on detached tomato leaves was similar
to that of the parental strain, B05.10 (data not shown).
DISCUSSION
Bcmfs1 is a new member of the MFS genes family encoding
transporters with 14 transmembrane domains. Phenotypic
FIG. 5. Activity of cercosporin and camptothecin on relative growth of B. cinerea wild-type strain B05.10 (), reference transformant HR-9
(), two Bcmfs1 replacement mutants, Bcmfs1-16 (F) and Bcmfs1-18 (Œ), and Bcmfs1 overexpression mutants OV1-23(), OV1-48 (E), and
OV1-13 (‚).




1)a of compound for:
B05.10 Bcmfs1-16 OV1–13 HR-9
DMIs Oxpoconazole 0.151 a 0.189 a 0.330 b 0.161 a
Prochloraz 0.031 ab 0.025 a 0.088 c 0.032 ab
Tebuconazole 0.161 a 0.151 a 0.337 b 0.136 a
Anilinopyri-
midine
Cyprodinil 0.0029 a 0.0022 a 0.0060 b 0.0025 a
Dicarboximide Iprodione 0.057 a 0.054 a 0.148 b 0.056 a
Phthalimide Captan 6.29 a 6.30 a 12.6 b 5.58 a
Phenylpyridyl-
amine
Fluazinam 0.0021 a 0.0021 a 0.0037 b 0.0019 a
Antibiotic Cycloheximide 3.42 b 3.55 b 1.94 a 3.10 ab
Xenobiotic Rhodamine 6G 1.53 ab 1.88 b 1.16 a 1.47 ab
a Means followed by the same letters in the same rows indicate that figures do
not differ significantly (P 
 0.05).
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characterization of replacement and overexpression mutants
indicated that the transporter provides protection against the
alkaloid camptothecin, the photosensitizer cercosporin (a per-
ylenequinone toxin), and DMI fungicides. Accumulation of the
DMI fungicide oxpoconazole by germlings of these mutants
and the parental strain, B05.10, and their sensitivity to oxpo-
conazole correlated with the expression of Bcmfs1. These re-
sults demonstrate that Bcmfs1 is a multidrug transporter in-
volved in protection against a wide range of chemicals.
Bcmfs1 has a high homology with aflT from A. parasiticus,
CFP1 from C. kikuchii, and TOXA from C. carbonum. The
homology with CFP1 may reflect why both Bcmfs1 and CFP1
are involved in protection against cercosporin. Like Bcmfs1,
MFS proteins from yeasts, such as BenR (15) and FLU1 (5)
from C. albicans and FLR1 (1) from S. cerevisiae, transport
DMI fungicides. However, these three yeast MFS proteins
have a low level of homology to Bcmfs1, suggesting that there
is no obvious relation between homology and substrate speci-
ficity.
The role of bcmfs1 in transport of DMI fungicides became
obvious only after functional inactivation in a BcatrD mutant
(Fig. 4B; Table 3). A similar phenomenon has been reported
with C. albicans for the ABC transporter CDR2, which showed
a phenotype only in mutants with a CDR1 background (28).
This can be ascribed to redundancy of transporters with an
overlap in substrate specificity. Previously, we demonstrated
that BcatrD is the major transporter of DMI fungicides in B.
cinerea (17). Hence, we assume that the lack of phenotype of
Bcmfs1 mutants with respect to sensitivity to DMIs is due to
compensating activity of BcatrD. However, such compensating
activity does not seem to be accompanied by increased tran-
scription of BcatrD, since basal and induced transcript levels of
the gene were similar in strains B05.10 and Bcmfs1-16 (Fig.
3B). The conclusion that Bcmfs1 mediates transport of DMIs
is supported by the observation that the Bcmfs1-overexpressing
mutants showed a significant reduction in DMI sensitivity (Fig.
4C; Table 2). BcatrB is not a DMI transporter (29, 33). Still,
expression of BcatrB is induced by treatment with DMI fungi-
cides (16), indicating that inducers of expression of BcatrB are
not necessarily a substrate of the encoded proteins. Similar
phenomena have been described for other ABC genes (17, 29).
Bcmfs1-overexpressing mutants display reduced sensitivity
to various unrelated fungicides (Fig. 4C; Table 2). This sug-
gests that the multidrug transporter Bcmfs1 has a low substrate
specificity for these products and that loss of the Bcmfs1 func-
tion in deletion mutants can be compensated for by other
transporters. Mutant OV1-13 has a slightly increased sensitiv-
ity to cycloheximide (Fig. 4C; Table 2). A similar phenomenon
was observed in multidrug-resistant mutants of A. nidulans
with resistance to DMIs and increased sensitivity to dithio-
carbamate fungicides and the antibiotic phleomycin (3). We
hypothesize that the increased sensitivity displayed by the over-
expression mutant could be due to the fact that MFS trans-
porters function as not only efflux but also influx transporters
(14).
The accumulation of oxpoconazole by germlings of B. cine-
rea was transient in time. The initial accumulation (up to 40
min) by OV1-13 was lower than that by B05.10 (Fig. 6), and the
accumulation by all strains correlated with their sensitivity to
the fungicide (Fig. 6; Tables 2 and 3). The steady-state level of
oxpoconazole accumulation (after 60 min) by D1-45 was
significantly higher than that by BcatrD-8. These observa-
tions indicate that mutations in Bcmfs1 indeed functionally
affect efflux of oxpoconazole. Besides BcatrD and Bcmfs1,
additional transporters in B. cinerea may exist that play a role
in efflux of DMI fungicides. This assumption is based on the
observation that the double-replacement mutant D1-45 still
displays a transient accumulation profile (Fig. 6), which sug-
gests that efflux activity still proceeds to a weak extent. The
transporter gene involved might be BcatrG and/or BcatrK,
since expression of these genes was induced by DMI fungicides
(16). Such a situation would indicate that multiple transporter
proteins mediate the transport of a particular compound. A
similar phenomenon has been described for C. albicans, which
possesses at least four transporter genes involved in efflux of
DMIs. These include the ABC transporter genes CDR1 (24)
FIG. 6. Accumulation of oxpoconazole (30 M) by germlings of B.
cinerea wild-type strain B05.10 (), reference transformant HNR-4
(), BcatrD single-replacement mutants BcatrD-8 (Œ), Bcmfs1 sin-
gle-replacement mutants Bcmfs1-16 (), BcatrD and Bcmfs1 double-
replacement mutant D1-45 (F), and Bcmfs1 overexpression mu-
tants OV1-13 (E).




1)a of compound for:
HNR-4b BcatrD-8 Bcmfs1–16 D1–45
DMIs Oxpoconazole 0.114 c 0.035 b 0.107 c 0.017 a
Prochloraz 0.026 c 0.014 b 0.016 b 0.005 a
Tebuconazole 0.110 c 0.087 b 0.105 c 0.035 a
Pyrifenox 0.046 b 0.036 b 0.044 b 0.021 a
Fenarimol 0.869 c 0.374 b 0.780 c 0.242 a
Alkaloid Camptothecin 10 b 10 b 0.68 a 0.70 a
a Means followed by the same letters in the same rows indicate that figures do
not differ significantly (P 
 0.05).
b EC50 values of compounds for wild-type strain B05.10 and HNR-4 do not
differ significantly (data not shown).
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and CDR2 (27) and the MFS genes CaBenR (26) and FLU1
(5).
It is probable that B. cinerea developed transporter systems
during evolution to cope with natural toxic compounds. How-
ever, in this context it is difficult to understand why camptoth-
ecin and cercosporin are substrates of Bcmfs1. Camptothecin
is an alkaloid compound with antitumor activity isolated from
Chinese tree C. acuminata. This plant is not known as a host of
B. cinerea. It might be that plant species within the wide host
range of B. cinerea contain the same or related alkaloids. Cer-
cosporin is a natural photoactivated toxin produced by Cerco-
spora species (9), and similar compounds are not known for
B. cinerea. It is not likely that they are produced during patho-
genesis, since necrotic symptoms incited by B. cinerea are light
independent. Bcmfs1 is also not a general transporter of pho-
tosensitizers, as shown for Snq2 (34). Hence, the potency of
Bcmfs1 for transport of cercosporin is hard to explain. A num-
ber of MFS transporters from filamentous fungi homologous
to Bcmfs1 can function as virulence factors. This is reported
for the cercosporin transporter from C. kikuchii (6), the HC
toxin transporter from C. carbonum (23), and the transporter
of trichothecenes from F. sporotrichioides (2). MFS genes in-
volved in secretion of HC toxin and trichothecenes are located
in a gene cluster carrying genes that encode enzymes involved
in biosynthesis of these toxins. A role for Bcmfs1 in secretion
of endogenous toxins is not obvious, since DNA sequences
flanking Bcmfs1 did not reveal the presence of genes involved
in toxin biosynthesis. Botrydial, produced by B. cinerea, is
toxic to sweet pepper (10). This toxin might be a substrate of
Bcmfs1, although disruption of Bcmfs1 did not increase the
sensitivity to botrydial analogues, such as patchoulol and
globulol (32). The virulence of all Bcmfs1 mutants tested on
detached tomato leaves was similar to that of the parental
strain, B05.10. For these reasons, the intrinsic function of
Bcmfs1 is still obscure. Such a function might become obvious
upon testing the virulence of replacement mutants on a wide
range of host plants. These studies are being performed in
current research, but so far no phenotype with respect to host
virulence has been found. It is also possible that Bcmfs1 func-
tions in protection against antibiotics produced by antagonistic
microorganisms during its saprophytic phase of growth. Such a
function has recently been reported for BcatrB of B. cinerea in
protection against phenazine antibiotics produced by Pseudo-
monas species (30). This hypothesis is currently being tested
for Bcmfs1 and other ABC and MFS transporters of B. cinerea.
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